Filing Details

Accession Number:
0001209191-19-004552
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-18 16:18:50
Reporting Period:
2019-01-17
Accepted Time:
2019-01-18 16:18:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1446372 M Paul Silva C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Svp & Corp Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-17 1,289 $91.05 17,376 No 4 M Direct
Common Stock Disposition 2019-01-17 1,289 $191.05 16,087 No 4 S Direct
Common Stock Acquisiton 2019-01-17 859 $90.29 16,946 No 4 M Direct
Common Stock Disposition 2019-01-17 859 $190.29 16,087 No 4 S Direct
Common Stock Acquisiton 2019-01-17 859 $90.29 16,946 No 4 M Direct
Common Stock Disposition 2019-01-17 859 $190.29 16,087 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-01-17 1,289 $0.00 1,289 $91.05
Common Stock Stock Option (Right to Buy) Disposition 2019-01-17 859 $0.00 859 $90.29
Common Stock Stock Option (Right to Buy) Disposition 2019-01-17 859 $0.00 859 $90.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,446 2026-02-01 No 4 M Direct
6,016 2026-07-11 No 4 M Direct
5,157 2026-07-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 169 Indirect 401(K)
Footnotes
  1. Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
  2. The option vests in 16 quarterly installments from 02/02/2016.
  3. The option vests in 16 quarterly installments from 07/12/2016.